Author Archives: admin


Dr. Todd Malan Named Chief Cell Therapy Officer at Okyanos Heart Institute

Freeport, The Bahamas (PRWEB) May 20, 2014

Okyanos Heart Institute has announced the addition of Dr. Todd Malan to their executive medical team as Chief Cell Therapy Officer and General Surgeon. He will perform and oversee the liposuction step of Okyanos treatment, removing a small amount of fat from patients from which their own stem cells are isolated. Cardiac cell therapy is intended for no-option heart patients who have exhausted the currently available standards of care for their condition, of which there are about 2 million in the United States alone.

Dr. Malan is founder of the Innovative Cosmetic Surgery Center in Scottsdale, Arizona, specializing in advanced liposuction and fat transfer procedures. A pioneer in adipose- (fat) derived stem cell research and fellow of the American Academy of Cosmetic Surgery, Dr. Malan became the first physician in the United States to utilize adult stem cells from fat tissue for soft tissue reconstruction. He has co-authored two medical textbooks on fat-derived stem cell therapies and has served as principal investigator on two Institutional Review Board- (IRB) approved adult stem cell trials.

As an active member of the adipose stem cell research community, Dr. Malan is very familiar with the therapeutic benefits of adult stem cells for cardiac, as demonstrated in clinical trials, said Dr. Howard Walpole, chief medical officer at Okyanos. He lends his experience and integrated knowledge of both innovative cosmetic surgery and stem cell therapy to our medical leadership team, he added.

"It is truly gratifying to see the gathering of like-minded researchers, clinicians, and administrators who see the remarkable value of developing evidence-based protocols for effective stem cell therapies, said Dr. Malan. He added, This project is a culmination of years of experience between industry leaders who are dedicated to making Okyanos a premier cell therapy center in the world. The work we do today will define the future of medicine for years to come."

Okyanos cardiac cell therapy is the first stem cell-based procedure for heart failure available to patients outside of clinical trials, wherein the patients own adipose-derived stem cells are infused directly into the damaged part of the heart via catheter. Okyanos will begin treating advanced heart disease patients in Freeport, The Bahamas, in the summer of 2014.

ABOUT OKYANOS HEART INSTITUTE: [Oh key AH nos] Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by founder and CEO Matt Feshbach, as well as Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.S.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive procedure, can stimulate the growth of new blood vessels, a process known as angiogenesis. Angiogenesis facilitates blood flow in the heart, which supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos, the Greek god of rivers, symbolizes restoration of blood flow.

For more information, please visit http://www.okyanos.com/.

Visit link:
Dr. Todd Malan Named Chief Cell Therapy Officer at Okyanos Heart Institute

Sabathia out until at least July

New York Yankees left-hander CC Sabathia, on the disabled list with a right knee injury, will be out until at least July.

Sabathia received a stem cell treatment injection in the inflamed knee from Dr. James Andrews last week.

Yankees general manager Brian Cashman told the New York Post that the team was informed that if the process works, Sabathia would need at least six weeks of recovery time.

"Our dialogue with Andrews has been good and the small sample of stem cell procedures, the results are very successful," Cashman said. "But he has to be pain free before strengthening, so there is a way to go. Because he is a starter it will take longer. I have no idea how long it will be and if it will be successful. We are hoping it is six weeks to a major league return."

Sabathia was scheduled to stop using crutches Monday and begin pool therapy on Tuesday. The Yankees hope Sabathia can steadily build strength in the knee and then go through an abridged spring training before getting back on the mound.

The Yankees are also without starter Ivan Nova for the season after having Tommy John surgery. Michael Pineda, who has an injured lat, is throwing bullpen sessions. Cashman said Pineda's target return date is in the second week of June.

The Yankees' current rotation includes Masahiro Tanaka, Hiroki Kuroda, David Phelps, Vidal Nuno and Chase Whitley. Cashman said Adam Warren is the next pitcher the team would turn to if it has a rotation spot opening due to injury or performance.

See the original post here:
Sabathia out until at least July

Groundbreaking hip and stem cell surgery in Southampton

PUBLIC RELEASE DATE:

16-May-2014

Contact: Becky Attwood r.attwood@soton.ac.uk 44-023-805-92116 University of Southampton

Doctors and scientists in Southampton have completed their first hip surgery with a 3D printed implant and bone stem cell graft.

The 3D printed hip, made from titanium, was designed using the patient's CT scan and CAD CAM (computer aided design and computer aided manufacturing) technology, meaning it was designed to the patient's exact specifications and measurements.

The implant will provide a new socket for the ball of the femur bone to enter. Behind the implant and between the pelvis, doctors have inserted a graft containing bone stem cells.

The graft acts as a filler for the loss of bone. The patient's own bone marrow cells have been added to the graft to provide a source of bone stem cells to encourage bone regeneration behind and around the implant.

Southampton doctors believe this is a game changer. Douglas Dunlop, Consultant Orthopaedic Surgeon, conducted the operation at Southampton General Hospital. He says: "The benefits to the patient through this pioneering procedure are numerous. The titanium used to make the hip is more durable and has been printed to match the patient's exact measurements this should improve fit and could recue the risk of having to have another surgery.

"The bone graft material that has been used has excellent biocompatibility and strength and will fill the defect behind the bone well, fusing it all together."

Over the past decade Mr Dunlop and Professor Richard Oreffo, at the University of Southampton, have developed a translational research programme to drive bone formation using patient skeletal stem cells in orthopaedics.

Original post:
Groundbreaking hip and stem cell surgery in Southampton

Beverly Hills Orthopedic Institute Now Offering Stem Cell Procedures for Cartilage Damage in Joints

Beverly Hills, CA (PRWEB) May 19, 2014

The top Beverly Hills orthopedic surgeon is now offering stem cell procedures for cartilage damage in joints. The procedures have been showing excellent potential for helping repair arthritis damage in joints along with focal defects due to trauma or sporting injuries. Call (310) 438-5343 for more information and scheduling.

As stem cell procedures for joint arthritis and cartilage damage become mainstream, Beverly Hills Orthopedic Institute is leading the way in helping patients achieve pain relief and avoid major surgery. Dr. Raj is the Double Board Certified Medical Director at the practice, and has been named one of the top LA orthopedic surgeons on several occasions.

Dr. Raj treats patients ranging from professional athletes to weekend warriors, to grandparents and celebrities. With exceptional experience in treating extremity joints with stem cell procedures, Dr. Raj is the "go to" regenerative medicine doctor in LA and Beverly Hills.

Multiple types of procedures are performed. The first option involves the patient's own bone marrow derived stem cells, which is a low risk, outpatient procedure. The bone marrow is immediately processed to concentrate the stem cells and injected into the problem joint.

The second type of procedure involves amniotic derived stem cells. These are harvested from consenting donors after scheduled c-sections and then processed at an FDA regulated lab. The amniotic derived fluid has been used over 20,000 times worldwide and is very rich in stem cells and growth factors.

Dr. Raj is an ABC News Medical Correspondent along with a WebMD medical expert. For those in need of pain relief and surgery avoidance with arthritis and cartilage defects, Dr. Raj at Beverly Hills Orthopedic Institute is the top choice in Los Angeles.

Call (310) 438-5343 for more information and scheduling.

Originally posted here:
Beverly Hills Orthopedic Institute Now Offering Stem Cell Procedures for Cartilage Damage in Joints

The Stem Cell Blog | Adult Stem Cell Patient Empowerment

In STEM CELLS IN THE NEWS on May 8, 2014 at 5:47 pm

NEW TREATMENT OPTIONS! There are many new treatment options from established and reputable clinics both inside and outside the USA. Treatment costs average $10-12,000 and financing is available for those that qualify. Many treatments include a 90 day PRP booster and banking to reduce costs on future treatments if required and/or desired. If you are interested, please email me at dsgrano@gmail.com Do not respond on here. If you havent already, please fill out the form at http://bit.ly/stemcellsnow

Like Loading...

CELL, clinic, fda, heal, RESEARCH, STEM, therapy, TREAT

But14 years late to the party. Reminds me of the last scene in Schindlers list. How many lives could have been saved? How much suffering could have been eased. Well, lets do the math.

in 2005 there were 2,448,000 deaths in the u.s. 4 of the top 6 killers were:

Heart disease (652,000 deaths) Cancer (559,000 deaths) Stroke (143,000 deaths) Diabetes (75,000 deaths)

There were a total of 1,429,000 deaths in 2005 from these 4 diseases and there are renowned stem cell treatment centers around the world that have been successfully treating patients with these disease for years. Around the world, people with these disease are actively receiving asc treatments and benefiting from them.

See more here:
The Stem Cell Blog | Adult Stem Cell Patient Empowerment

The Adult Stem Cell Foundation

ADULT STEM CELL THERAPY IS AVAILABLE NOW!

Australia - New Zealand - Asia & Pacific Rim - China - Italy

watch the latest video here

Our Foundation is a philanthropic (not for profit) charitable organization that will advise un-well people how to get access to Adult Stem Cell Therapy (ASCT). The Foundation will also promote a campaign showing how it is possible to prevent or limit the progression of these degenerative diseases to the general public. Degenerative disease is an uncontrolled escalating world problem that if not controlled has the ability to bankrupt our health systems. Very little is being done to control this epidemic in Degenerative Disease.

The purpose of the Foundation is to show that people suffering from a degenerative disease like Parkinsons, Multiple Sclerosis, Diabetes 1 & 2, Stroke, Alzheimers, Spinal Cord injuries, Liver diseases, Myocardial infarction, (to name a few) can now receive Adult Stem Cell Therapy that may change their quality of life for the better. That there is now HOPE.

The Foundation wants to especially help children suffering from any debilitating or degenerative disease, for example like Cerebral Palsy, Muscular Dystrophy, Autism, Spinal injuries, Cystic fibrosis, ADHD to name a few. Stem cell treatments have progressed in leaps and bounds in these areas and we have state of the art clinics that specialize in these types of child diseases. Children, because they are still growing can usually benefit substantially from an early intervention using stem cell therapies. Just fill out the Application Formfor a experimental transplant and we will be only to happy to advise both the parents or a fund raising group seeking to help a particular child.

The Adult Stem Cell Foundation has also become the Information Centre in Australasia for clinics that have demonstrated they abide by the highest medical standards, and have a proven track record with these therapies.

Original post:
The Adult Stem Cell Foundation

Ground breaking hip and stem cell surgery completed using 3D-printed implant

Doctors and scientists in Southampton have completed their first hip surgery with a 3D printed implant and bone stem cell graft.

The 3D printed hip, made from titanium, was designed using the patient's CT scan and CAD CAM (computer aided design and computer aided manufacturing) technology, meaning it was designed to the patient's exact specifications and measurements.

The implant will provide a new socket for the ball of the femur bone to enter. Behind the implant and between the pelvis, doctors have inserted a graft containing bone stem cells.

The graft acts as a filler for the loss of bone. The patient's own bone marrow cells have been added to the graft to provide a source of bone stem cells to encourage bone regeneration behind and around the implant.

Southampton doctors believe this is a game changer. Douglas Dunlop, Consultant Orthopaedic Surgeon, conducted the operation at Southampton General Hospital. He says: "The benefits to the patient through this pioneering procedure are numerous. The titanium used to make the hip is more durable and has been printed to match the patient's exact measurements -- this should improve fit and could recue the risk of having to have another surgery.

"The bone graft material that has been used has excellent biocompatibility and strength and will fill the defect behind the bone well, fusing it all together."

Over the past decade Mr Dunlop and Professor Richard Oreffo, at the University of Southampton, have developed a translational research programme to drive bone formation using patient skeletal stem cells in orthopaedics.

The graft used in this operation is made up of a bone scaffold that allows blood to flow through it. Stem cells from the bone marrow will attach to the material and grow new bone. This will support the 3D printed hip implant.

Professor Oreffo comments: "The 3D printing of the implant in titanium, from CT scans of the patient and stem cell graft is cutting edge and offers the possibility of improved outcomes for patients.

"Fractures and bone loss due to trauma or disease are a significant clinical and socioeconomic problem. Growing bone at the point of injury alongside a hip implant that has been designed to the exact fit of the patient is exciting and offers real opportunities for improved recovery and quality of life."

Read the rest here:
Ground breaking hip and stem cell surgery completed using 3D-printed implant

Chances of stem cell hip surgery 'very slim'

Chances of stem cell hip surgery 'very slim'

6:00am Saturday 17th May 2014 in News By Melanie Adams, Health Reporter

IT IS a revolutionary new operation that uses a 3D hip printed from a machine.

But the chances of you having hip surgery using the state-of-the-art implant and stem cells is very slim - according to a Southampton expert.

Only a minority of hip replacement patients will have access to the sophisticated technique that was pioneered at Southampton General Hospital this week.

It is the first time that doctors and scientists in the city have done hip surgery using a 3D printed implant in combination with bone stem cells graft.

It is hoped that the new titanium hip, which was designed using the patient's CT scan and state-of-the-art technology, will last longer because it has been made to fit the patient's exact measurements.

Meryl Richards, from Hampshire, who has had hip troubles since she was involved in a traffic accident in the 1970's, was the patient to receive this revolutionary hip.

Vitali Goriainov, a clinical registrar working at the University of Southampton, told the Daily Echo that the operation offers an alternative for the most complicated of hip patients, like Mrs Richards who has had several operations on her hip but still suffered excruciating pain.

For these patients the surgery, which was conducted by Douglas Dunlop, Consultant Orthopaedic Surgeon, is now available and the hospital already has two more patients lined up for the operation.

Read the original post:
Chances of stem cell hip surgery 'very slim'

Ground breaking hip and stem cell surgery completed using 3D printed implant

Doctors and scientists in Southampton have completed their first hip surgery with a 3D printed implant and bone stem cell graft.

The 3D printed hip, made from titanium, was designed using the patient's CT scan and CAD CAM (computer aided design and computer aided manufacturing) technology, meaning it was designed to the patient's exact specifications and measurements.

The implant will provide a new socket for the ball of the femur bone to enter. Behind the implant and between the pelvis, doctors have inserted a graft containing bone stem cells.

The graft acts as a filler for the loss of bone. The patient's own bone marrow cells have been added to the graft to provide a source of bone stem cells to encourage bone regeneration behind and around the implant.

Southampton doctors believe this is a game changer. Douglas Dunlop, Consultant Orthopaedic Surgeon, conducted the operation at Southampton General Hospital. He says: "The benefits to the patient through this pioneering procedure are numerous. The titanium used to make the hip is more durable and has been printed to match the patient's exact measurements -- this should improve fit and could recue the risk of having to have another surgery.

"The bone graft material that has been used has excellent biocompatibility and strength and will fill the defect behind the bone well, fusing it all together."

Over the past decade Mr Dunlop and Professor Richard Oreffo, at the University of Southampton, have developed a translational research programme to drive bone formation using patient skeletal stem cells in orthopaedics.

The graft used in this operation is made up of a bone scaffold that allows blood to flow through it. Stem cells from the bone marrow will attach to the material and grow new bone. This will support the 3D printed hip implant.

Professor Oreffo comments: "The 3D printing of the implant in titanium, from CT scans of the patient and stem cell graft is cutting edge and offers the possibility of improved outcomes for patients.

"Fractures and bone loss due to trauma or disease are a significant clinical and socioeconomic problem. Growing bone at the point of injury alongside a hip implant that has been designed to the exact fit of the patient is exciting and offers real opportunities for improved recovery and quality of life."

Excerpt from:
Ground breaking hip and stem cell surgery completed using 3D printed implant

Ground breaking hip and stem cell surgery in Southampton

PUBLIC RELEASE DATE:

16-May-2014

Contact: Becky Attwood r.attwood@soton.ac.uk 44-023-805-92116 University of Southampton

Doctors and scientists in Southampton have completed their first hip surgery with a 3D printed implant and bone stem cell graft.

The 3D printed hip, made from titanium, was designed using the patient's CT scan and CAD CAM (computer aided design and computer aided manufacturing) technology, meaning it was designed to the patient's exact specifications and measurements.

The implant will provide a new socket for the ball of the femur bone to enter. Behind the implant and between the pelvis, doctors have inserted a graft containing bone stem cells.

The graft acts as a filler for the loss of bone. The patient's own bone marrow cells have been added to the graft to provide a source of bone stem cells to encourage bone regeneration behind and around the implant.

Southampton doctors believe this is a game changer. Douglas Dunlop, Consultant Orthopaedic Surgeon, conducted the operation at Southampton General Hospital. He says: "The benefits to the patient through this pioneering procedure are numerous. The titanium used to make the hip is more durable and has been printed to match the patient's exact measurements this should improve fit and could recue the risk of having to have another surgery.

"The bone graft material that has been used has excellent biocompatibility and strength and will fill the defect behind the bone well, fusing it all together."

Over the past decade Mr Dunlop and Professor Richard Oreffo, at the University of Southampton, have developed a translational research programme to drive bone formation using patient skeletal stem cells in orthopaedics.

Read the original:
Ground breaking hip and stem cell surgery in Southampton